Structure based on 3bqd |
Ideal structure |
|
| Name: 1-[(1r,2r,3as,3bs,10ar,10bs,11s,12as)-1,11-dihydroxy-2,5,10a,12a-tetramethyl-7-phenyl-1,2,3,3a,3b,7,10,10a,10b,11,12,12a-dodecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl]-2-hydroxyethanone |
| Formula: C30 H36 N2 O4 |
| Weight: 488.618 |
| SMILES: "C[CH]1C[CH]2[CH]3C=C(C)C4=Cc5n(ncc5C[C]4(C)[CH]3[CH](O)C[C]2(C)[C]1(O)C(=O)CO)c6ccccc6" |
| Spacial conformation based on PDB
3bqd |
RESIDUE DAY 72
CONECT C1 4 C2 C10 H1 H1A
CONECT O1 2 C11 HO1
CONECT C2 3 C1 C3 C22
CONECT C3 3 C2 C4 N1
CONECT C4 3 C3 C5 H4
CONECT C5 3 C4 C6 C10
CONECT C6 3 C5 C7 C28
CONECT C7 3 C6 C8 H7
CONECT C8 4 C7 C9 C14 H8
CONECT C9 4 C8 C10 C11 H9
CONECT C10 4 C1 C5 C9 C19
CONECT C11 4 O1 C9 C12 H11
CONECT C12 4 C11 C13 H12 H12A
CONECT C13 4 C12 C14 C17 C18
CONECT C14 4 C8 C13 C15 H14
CONECT C15 4 C14 C16 H15 H15A
CONECT C16 4 C15 C17 C30 H16
CONECT C17 4 C13 C16 C20 O2
CONECT C18 4 C13 H18 H18A H18B
CONECT C19 4 C10 H19 H19A H19B
CONECT C20 3 C17 C21 O3
CONECT C21 4 C20 O4 H21 H21A
CONECT N1 3 C3 N2 C24
CONECT O2 2 C17 HO2
CONECT O3 1 C20
CONECT O4 2 C21 HO4
CONECT C22 3 C2 N2 H22
CONECT N2 2 N1 C22
CONECT C23 3 C24 C25 H23
CONECT C24 3 N1 C23 C27
CONECT C25 3 C23 C26 H25
CONECT C26 3 C25 C29 H26
CONECT C27 3 C24 C29 H27
CONECT C29 3 C26 C27 H29
CONECT C28 4 C6 H28 H28A H28B
CONECT C30 4 C16 H30 H30A H30B
CONECT H1 1 C1
CONECT HO1 1 O1
CONECT H4 1 C4
CONECT H1A 1 C1
CONECT H7 1 C7
CONECT H8 1 C8
CONECT H9 1 C9
CONECT H11 1 C11
CONECT H12 1 C12
CONECT H12A 1 C12
CONECT H14 1 C14
CONECT H15 1 C15
CONECT H15A 1 C15
CONECT H16 1 C16
CONECT H18 1 C18
CONECT H18A 1 C18
CONECT H18B 1 C18
CONECT H19 1 C19
CONECT H19A 1 C19
CONECT H19B 1 C19
CONECT H21 1 C21
CONECT H21A 1 C21
CONECT HO2 1 O2
CONECT HO4 1 O4
CONECT H22 1 C22
CONECT H23 1 C23
CONECT H25 1 C25
CONECT H26 1 C26
CONECT H27 1 C27
CONECT H29 1 C29
CONECT H28 1 C28
CONECT H28A 1 C28
CONECT H28B 1 C28
CONECT H30 1 C30
CONECT H30A 1 C30
CONECT H30B 1 C30
END
HET DAY 72
HETSYN DAY Deacylcortivazol; 11beta,17,21-Trihydroxy-6,16alpha-dim
HETSYN 2 DAY ethyl-2'-phenyl-2'H-pregna-2,4,6-trieno(3,2-c)pyrazol-2
HETSYN 3 DAY 0-one; 2'H-Pregna-2,4,6-trieno(3,2-c)pyrazol-20-one; 11
HETSYN 4 DAY ,17,21-trihydroxy-6,16-dimethyl-2'-phenyl-(11beta,16alp
HETSYN 5 DAY ha)-(9CI); 6,16A-DIMETHYLPREGNA-4,6-DIENE-11B,17A,21-TR
HETSYN 6 DAY IOL-20-ONE-2'-PHENYL-(3,2-C)- PYRAZO
HETNAM DAY 1-[(1R,2R,3aS,3bS,10aR,10bS,11S,12aS)-1,11-dihydroxy-2,
HETNAM 2 DAY 5,10a,12a-tetramethyl-7-phenyl-1,2,3,3a,3b,7,10,10a,10b
HETNAM 3 DAY ,11,12,12a-dodecahydrocyclopenta[5,6]naphtho[1,2-f]inda
HETNAM 4 DAY zol-1-yl]-2-hydroxyethanone
FORMUL DAY C30 H36 N2 O4
MONOMER page